Gene · 148
Papers1,657
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,657
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Predicting clinical outcomes from off-target receptor interactions using Secondary Intelligence™. | J Pharmacol Toxicol Methods | 2025 | 39577752 | PubTator, text mining | PubMed |
| Combinatorial prediction of therapeutic perturbations using causally-inspired neural networks. | bioRxiv | 2025 | 38260532 | PubTator, text mining | PubMed |
| Genetic Variants Linked to Dyslexia Co-Morbid ADHD: A Case Study of a Pakistani Outpatient. | J Popul Ther Clin Pharmacol | 2024 | 40926959 | PubTator, text mining | PubMed |
| Pan-Cancer Insights: A Study of Microbial Metabolite Receptors in Malignancy Dynamics. | Cancers (Basel) | 2024 | 39766077 | PubTator, text mining | PubMed |
Discovering the Bioactive Compounds Binding to α1A-Adrenergic Receptor in Guizhi Fuling Formula and Revealing Their Interactions by Immobilizing the Receptor Through Colicin L7 DNase/Immunity Protein 7 Ultra-Affinity System. | J Sep Sci | 2024 | 39658822 | PubTator, text mining | PubMed |
| Polypharmacological profiling across protein target families and cellular pathways using the multiplexed cell-based assay platform safetyProfiler reveals efficacy, potency and side effects of drugs. | Biomed Pharmacother | 2024 | 39405910 | PubTator, text mining | PubMed |
| [Establishment and evaluation of haloalkane dehalogenase tagged α1A-adrenergic receptor chromatography]. | Se Pu | 2024 | 39327657 | PubTator, text mining | PubMed |
| Sustained fentanyl exposure inhibits neuronal activity in dissociated striatal neuronal-glial cocultures through actions independent of opioid receptors. | J Neurophysiol | 2024 | 39110896 | PubTator, text mining | PubMed |
| Ligand-Receptor Interactions and Structure-Function Relationships in Off-Target Binding of the β3-Adrenergic Agonist Mirabegron to α1A-Adrenergic Receptors. | Int J Mol Sci | 2024 | 39000575 | PubTator, text mining | PubMed |
| In Vitro Activation of Human Adrenergic Receptors and Trace Amine-Associated Receptor 1 by Phenethylamine Analogues Present in Food Supplements. | Nutrients | 2024 | 38892500 | PubTator, text mining | PubMed |
| Structure-Based Drug Design of ADRA2A Antagonists Derived from Yohimbine. | J Med Chem | 2024 | 38857067 | PubTator, text mining | PubMed |
| Exploring the Role of Non-synonymous and Deleterious Variants Identified in Colorectal Cancer: A Multi-dimensional Computational Scrutiny of Exomes. | Curr Genomics | 2024 | 38544823 | PubTator, text mining | PubMed |
| The 8-hydroxyquinoline derivative, clioquinol, is an alpha-1 adrenoceptor antagonist. | Biochem Pharmacol | 2024 | 38408679 | PubTator, text mining | PubMed |
| AKT2S128/CCTαS315/319/323-positive cancer-associated fibroblasts (CAFs) mediate focal adhesion kinase (FAK) inhibitors resistance via secreting phosphatidylcholines (PCs). | Signal Transduct Target Ther | 2024 | 38280862 | PubTator, text mining | PubMed |
| Identification of a Novel Subtype-Selective α1B-Adrenoceptor Antagonist. | ACS Chem Neurosci | 2024 | 38238043 | PubTator, text mining | PubMed |
| EDNRB inhibits the growth and migration of prostate cancer cells by activating the cGMP-PKG pathway. | Open Med (Wars) | 2024 | 38205153 | PubTator, text mining | PubMed |
| CardiOmics signatures reveal therapeutically actionable targets and drugs for cardiovascular diseases. | Heliyon | 2024 | 38187312 | PubTator, text mining | PubMed |
| Mechanisms and treatment of obesity-related hypertension-Part 1: Mechanisms. | Clin Kidney J | 2024 | 38186879 | PubTator, text mining | PubMed |
| NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases. | Redox Biol | 2024 | 38150994 | PubTator, text mining | PubMed |
| Differences in vasomotor function of mesenteric arteries between Ossabaw minipigs with predisposition to metabolic syndrome and Göttingen minipigs. | Am J Physiol Heart Circ Physiol | 2024 | 38133620 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/148/papers?page=3